id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1683453,a4863211-ec4e-4e0d-b10b-4df67d004ad2,Q1,BIOTECHNOLOGY INNOVATION ORGANIZATION,6245,BIOTECHNOLOGY INNOVATION ORGANIZATION,2015,first_quarter,MMM,"Independent Payment Advisory Board
 
Reimbursement for Innovative Products
     -Medicare Part D Prescription Drug Program
     -Medicare Part B Physician-Administered Products
    
Medicare Physician Payment Sustainable Growth Rate Formula 
     -HR 2: Medicare Access and CHIP Reauthorization Act of 2015

21st Century Cures Initiative
     -Patient Access to Approved Drugs
     -Coding 
     -Coverage with Evidence Development","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Treasury, Dept of,U.S. Trade Representative (USTR),White House Office",,2010000,0,0,2015-04-20T17:59:01.790000-04:00